skip to Main Content

Globally, 1 in 4 people are living with fatty liver disease, with obesity, alcohol consumption, and sedentary lifestyles as key contributors.

EASL has been actively working to beat liver disease, including NAFLD & NASH, through its schools and key event, the NAFLD Summit. EASL has also developed a Policy Statement on the measures required to prevent and treat this common progressive condition. Globally, 1 in 4 people are living with fatty liver disease, with obesity, alcohol consumption, and sedentary lifestyle behaviours as key contributors.

Fatty liver is a silent but deadly epidemic with many people remaining asymptomatic well into the advanced stages of disease. The development of new therapies, the use of biomarkers in NAFLD, and how microbiota and genes can modulate alcohol-related liver disease (ALD) are current key research questions that will be addressed during Digital ILC 2020.

Digital ILC 2020 highlights: NAFLD pharmacological therapy abstracts session

What progress is underway in NAFLD pharmacological therapy? How has this active research field evolved since ILC 2019? Watch this video to get the “NAFLD pharmacological therapy” highlights from the session Co-Chair, Prof. Sven Francque.

Explore the Metabolism, Alcohol and Toxicity track at Digital ILC 2020

In the Metabolism, Alcohol and Toxicity track at Digital ILC 2020, world-renowned experts will examine the metabolic factors associated with liver disease, and how they interact with genetics, inflammation, and the gut–liver axis. Follow this track to learn about the interaction of all these factors and highlight promising new research in screening, monitoring, and treatment.
Discover below all the sessions regarding metabolism, alcohol and toxicity at Digital ILC 2020:

Abstract session: NAFLD – Non invasive assessment

27 August 2020 11:00 – 12:30

Chairs: Victor de Lédinghen (France), Manuel Romero Gomez (Spain)

Read more

Abstract session: Alcohol associated liver disesase

27 August 2020 11:00 – 12:30

Chairs: Marsha Morgan (United Kingdom), Alexandre Louvet (France)

Read more

Abstract session: NAFLD – Clinical except therapy

27 August 2020 15:30 – 17:00

Chairs: Luca Miele (Italy), Raluca Pais (France)

Read more

Abstract session: NAFLD – Pharmacological therapy

28 August 2020 11:00 – 12:30

Chairs: Elisabetta Bugianesi (Italy), Sven Francque (Belgium)

Read more

Abstract session: NAFLD – Target identification and drug pipeline

28 August 2020 15:30 – 17:00

Chairs: Frank Tacke (Germany), Luca Valenti (Italy)

Read more

Abstract session: NAFLD – Experimental

29 August 2020 11:00 – 12:30

Chair: Amalia Gastaldelli (Italy)

Read more

Meet the Experts: Non-invasive assessment in NAFLD

27 August 2020 09:15 – 09:45

Chairs: Massimo Pinzani (United Kingdom), Maja Thiele (Denmark)

Read more

Optimal endpoints in NAFLD clinical trials – Histology or non-invasive biomarkers and imaging?

27 August 2020 17:00 – 18:00

Chairs: Manal Abdelmalek (United States), Mattias Ekstedt (Sweden)

Read more

Precision medicine for the management of NAFLD – Are we there yet?

29 August 2020 15:30 – 17:00

Stefano Romeo (Sweden)

Read more

Poster tour: NAFLD: Clinical aspects except therapy

27 August 2020 12:30 – 13:00

Chair: Salvador Augustin, Spain

Read more

Poster tour: NAFLD: Diagnostics and non-invasive assessment

27 August 2020 15:00 – 15:30

Chair: Isabel Graupera (Spain)

Read more

Poster tour: NAFLD: Experimental and pathophysiology

28 August 2020 12:30 – 13:00

Chair: Tom Lüdde, Germany

Read more

Poster tour: NAFLD: Therapy

28 August 2020 15:00 – 15:30

Chair: Francesca Ponziani, Italy

Read more

Poster tour: Alcoholic liver disease

29 August 2020 12:30 – 13:00

Chair: Philippe Mathurin (France)

Read more

Poster tour: Acute liver failure and drug induced liver injury

29 August 2020 15:00 – 15:30

Chair: Maria Isabel Lucena (Spain)

Read more

Digital ILC 2020 wrap up session – NAFLD/NASH/Alcoholic liver disease

29 August 2020 18:08 – 18:28

Chair: William Alazawi (United Kingdom)

Read more

Prepare yourself for Digital ILC 2020

Selected articles from the Journal of Hepatology:

Discover over 320 dedicated resources on EASL Campus

Browse the resources

Obesity is feeding the rise in NAFLD across Europe

Read the Policy Statement

(Re)discover the “Best of ILC 2019” Slide Deck

Read now

A snapshot of NAFLD, a looming public health crisis worldwide

Watch the video now

View over 160 open access resources from the NAFLD Summit 2019

View resources

Review the open access content from the NAFLD Summit 2019

Read now

Share